Displaying 1 - 6 of 6
  • Print
Preparations (1) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient ASPIRIN | DIPYRIDAMOLE
Therapeutic Class VASODILATING AGENTS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (5) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient BETAHISTINE
Therapeutic Class VASODILATING AGENTS
Indications Vertigo, tinnitus and hearing loss associated with Mé•nière'sdisease.
Caution Gastro-intestinal disturbances; headache; pruritus; rashes. Betahistine should be given with care to patients with asthma, peptic ulcer disease or a history pepticulcer disease.
Dose Range Initially 16mg 3 times a day, maintenance 24-48mg daily. Dose preferably taken with food.
Drug Interactions
Pregnancy Avoid unless clearly necessary.
Breast Feeding Use only if potential benefit outweighs risk.
Preparations Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient VASODILATING AGENTS
Therapeutic Class VASODILATING AGENTS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (4) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient ALPROSTADIL
Therapeutic Class VASODILATING AGENTS, MISCELLANEOUS
Indications Congenital heart disease in neonates until surgery is possible.
Caution Infants: apnoea, fever, flushing, hypotension, bradycardia, tachycardia, diarrhoea, and convulsions.
Dose Range Pediatric: Continuous intravenous infusion, initially 5 nanograms /kg/ minute, adjusted according to response, adjusted in steps of 5 nanograms/ kg / minute ( max . Per dose 100 nanograms /kg/minute),
Drug Interactions
Pregnancy
Breast Feeding
Preparations Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient PAPAVERINE
Therapeutic Class VASODILATING AGENTS, MISCELLANEOUS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (5) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient BOSENTAN
Therapeutic Class VASODILATING AGENTS MISCELLANEOUS
Indications Pulmonary Hypertension.
Caution Contra-indicated in patients with moderate to severe hepatic impairment, headache, nasopharyngitis, flushing, oedema, hypotension, dizziness, palpitations, gastrointestinal disturbances, pruritus More ...
Dose Range 12 years and older: Initially 62.5 mg twice daily, increased after 4 weeks to a maintenance dose of 125 mg twice daily. Patients with low body weight (below 40kg) 62.5 mg twice daily.
Drug Interactions
Pregnancy
Breast Feeding